RadNet filed a prospectus supplement to register the resale of up to 34,069 shares of common stock by See-Mode Sellers. These shares were issued as part of the share component of payment for satisfying milestone conditions under a Share Purchase Agreement dated June 2, 2025, involving DH AI International Holdings, B.V., a wholly-owned subsidiary of RadNet. The filing includes an opinion from Executive Vice President and Chief Legal Officer David J. Katz regarding the legality of the securities. RadNet operates in the medical imaging industry, providing diagnostic imaging services.

RadNet, Inc. reported second quarter 2026 financial results on August 9, 2026, achieving record quarterly revenue of $622.7 million, a 25.0% increase from the prior year period. Adjusted EBITDA reached a record $99.7 million, up 22.7%, while Digital Health segment revenue grew 56.5% to $32.4 million with Annual Recurring Revenue doubling to $105.5 million. The company revised its full-year 2026 Imaging Center guidance upward, raising total net revenue expectations to a range of $2,370–$2,420 million and Adjusted EBITDA to $345–$358 million. As of June 30, 2026, RadNet held $726.3 million in cash with a Net Debt to Adjusted EBITDA ratio of 1.8x. RadNet operates as a national provider of outpatient diagnostic imaging services and radiology information technology solutions.

RadNet, Inc. entered into the Third Amendment to its Credit and Guaranty Agreement on June 10, 2026, adding a $250.0 million 2026 Incremental Term Loan to its existing term loan facility. The amendment includes a reduction in interest rates by 0.25% for both the term loan and the existing $282 million revolving credit facility, while increasing quarterly principal payments to approximately $3.1 million. RadNet, Inc. intends to use the proceeds from the new loan to fund future acquisitions, organic expansion, and general corporate purposes. RadNet, Inc. operates in the healthcare industry and provides diagnostic imaging services.